[Monoamine oxidase inhibitors as pharmaceutical agents].
D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007490:Iproniazid / Q000627:therapeutic use; D007520:Isocarboxazid / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D009526:Nialamide / Q000627:therapeutic use; D010293:Pargyline / Q000627:therapeutic use; D010624:Phenelzine / Q000627:therapeutic use; D014191:Tranylcypromine / Q000627:therapeutic use
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D007520:Isocarboxazid; D014191:Tranylcypromine; D010293:Pargyline; D007490:Iproniazid; D010624:Phenelzine; D009526:Nialamide
Inhibitory fermentu monoaminoksydazy iak likars'ki zasoby.